In a small substudy N 81 of the NSABP P 1 trial, there appeared to be no benefit to screening women for Factor V Leiden and Prothrombin mutations G20210A as a means to identify those who may not be appropriate candidates for Tamoxifen Citrate Actavis tamoxifen citrate therapy nolvadex...